Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Sioux Falls, South Dakota 57105


Purpose:

This is a pilot study to determine the safety and efficacy of an investigational product (IHBG-10) on weight loss, and changes in body composition.


Study summary:

Subjects will be randomized to one of two groups: one group will take 500 mg of the investigational product (IHBG-10) 15 minutes prior to the three main meals of the day; the other group will take placebo 15 minutes prior to the three main meals of the day. Subjects will be on the investigational product or placebo for 12 weeks. Participation in this study involves four study visits.


Criteria:

Inclusion Criteria: - Age 18 and older - Body mass index of 30 or greater - Agree to keep diet, exercise and all current health habits stable during participation in the study Exclusion Criteria: - Women who are pregnant, breastfeeding or planning to become pregnant - Prior bariatric surgery - Use of prescription or over-the-counter appetite suppressants, herbal products or other medications for weight loss within the past month - Obesity as a result of a clinically diagnosed endocrine problem - Currently taking an anti-psychotic medication - History of peptic ulcer disease


NCT ID:

NCT01272739


Primary Contact:

Principal Investigator
Edward Zawada, MD
Avera McKennan Hospital & University Health Center


Backup Contact:

N/A


Location Contact:

Sioux Falls, South Dakota 57105
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: August 31, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.